Long-term response to peginterferon in hepatitis C virus-associated nephrotic syndrome from focal segmental glomerulosclerosis

Renal Failure

Volumn 35, Issue 8, 2013, Pages 1182-1185

  Shah, Hitesh H ^a   Patel, Chinmay ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Focal segmental glomerulosclerosis (FSGS); Glomerulonephritis; Hepatitis C infection; Nephropathy; Peginterferon therapy

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; CHOLESTEROL; CREATININE; FUROSEMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEGINTERFERON ALPHA2A; SERUM ALBUMIN; VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; EDEMA; ELECTRON MICROSCOPY; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GENOTYPE; GLOMERULUS; HEPATITIS C; HISPANIC; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LEG EDEMA; LIVER BIOPSY; MALE; MONOTHERAPY; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RNA VIRUS; SEROLOGY; TREATMENT RESPONSE; ULTRASOUND;

ANTIVIRAL AGENTS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS;

EID: 84881586662     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.815568     Document Type: Article

References (22)

1. Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002; 36: S30-S34.
2. Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep. 2006; 8: 53-59.
3. Fabrizi F, Dixit V, Martin P, Messa P. The evidence-based epidemiology of HCV-associated kidney disease. Int J Artif Organs. 2012; 35: 621-628.
4. Stehman-Breen C, Alpers CE, Couser W, et al. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol. 1995; 43: 141-147.
5. Sumida K, Ubara Y, Hoshino J, Suwabe T, Nakanishi S, Hiramatsu R, et al. Hepatitis C virus-related kidney disease: various histological patterns. Clin Nephrol. 2010; 74: 446-456.
6. Markowitz GS, Cheng JT, Colvin RB, Trebbin WM. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 1998; 9: 2244-2252.
7. Altraif IH, Abdulla AS, al Sebayel MI, Said RA, al Suhaibani MO, Jones AA. Hepatitis C associated glomerulonephritis. Am J Nephrol. 1995; 15: 407-410.
8. Choo Q-L, Kuo G, Wener AJ, et al. Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244: 359-362.
9. Noureddine LA, Usman SA, Yu Z, Moorthi RN, Moe SM. Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis. Am J Nephrol. 2010; 32: 311-316.
10. Fabrizi F, Martin P, Dixit V, Messa P. Hepatitis C virus infection and kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2012; 7: 549-557.
11. Fabrizi F, Pozzi C, Farina M, Dattolo P, Lunghi G, Badalamenti S, et al. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant. 1998; 13: 1991-1997.
12. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C infection. N Engl J Med. 1993; 328: 465-470.
13. McGuire BM, Julian BA, Bynon Jr JS, et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med. 2006; 144: 735-741.
14. Ezaki Y, Tanaka U, Minoshima S, et al. FSGS associated with hepatitis C and decrement of proteinuria by interferon. Nippon Jinzo Gakkai. 1999; 41: 83-88.
15. Bruchfeld A, Lindahl K, Stahle L, et al. Interferon and ribavirin treatment in patients with hepatitis C associated renal disease and renal insufficiency. Nephrol Dial Transplant. 2003; 18: 1573-1580.
16. Yamabe H, Johnson RJ, Gretch Dr, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol. 1995; 6: 220-223.
17. Abou-Zeid AA, El-Sayegh HK. Toll-like receptor 3 gene expression in Egyptian patients with glomerulonephritis and hepatitis C virus infection. Scand J Clin Lab Invest. 2011; 71: 456-461.
18. Sansonno D, Lauletta G, Montrone M, et al. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture micro dissection. Clin Expt Immunology. 2005; 140: 498-506.
19. Motta M, Malaguarnera M, Restuccia N, Romano M, Vinci E, Pistone G. Focal segmental glomerulosclerosis and hepatitis C virus: a case report. Panminerva Med. 2001; 43: 49-52.
20. Mihm U, Herrmann E, Sarrazin C, Zeuzem S. Review article: predicting response in hepatitis C virus therapy. Aliment Pharmacol Ther. 2006; 23: 1043-1054.
21. Morales JM, Kamar N, Rostaing L. Hepatitis C and renal disease: epidemiology, diagnosis, pathogenesis and therapy. Contrib Nephrol. 2012; 176: 10-23.
22. Sperati J. Stabilization of Hepatitis C associated collapsing focal segmental glomerulosclerosis with interferon a-2a and ribavirin. Clin Nephrol 2012. doi 10.5414/CN107337.